These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 6482605)

  • 1. [Hydralazine in chronic heart failure].
    Conradson TB; Rydén L
    Lakartidningen; 1984 Sep; 81(38):3354-5. PubMed ID: 6482605
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chronic treatment with vasodilators of heart failure. I. Hydralazine treatment].
    Dumitriu M; Costică II; Cinteză M; Dăescu L; Bălan C
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1984; 36(4):349-63. PubMed ID: 6150539
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of hydralazine therapy in patients with chronic congestive heart failure].
    Ke YN
    Zhonghua Nei Ke Za Zhi; 1987 Mar; 26(3):149-51, 190. PubMed ID: 3622085
    [No Abstract]   [Full Text] [Related]  

  • 4. [Vasodilator therapy in management of chronic heart failure (author's transl)].
    Letac B; Champoud O; Moore N
    Therapie; 1981; 36(1):1-10. PubMed ID: 7015550
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of hydralazine on systemic hemodynamics in patients with cardiac insufficiency].
    Koshlia VI
    Klin Med (Mosk); 1985 Oct; 63(10):100-2. PubMed ID: 4079283
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative efficacy of digoxin, hydralazine and combination therapy in chronic congestive heart failure.
    Patel HR; Thorat PB; Patel KH; Mehta NC; Shah CP
    J Assoc Physicians India; 1986 Jun; 34(6):422-4. PubMed ID: 3771482
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chronic Chagas' cardiopathy-- use of vasodilators in uncompensated heart failure].
    Marin-Neto JA; Secches AL; Maciel BC; Gallo Júnior L; Terra-Filho J; Manço JC; Amorin DS
    Arq Bras Cardiol; 1982 Apr; 38(4):291-9. PubMed ID: 7168662
    [No Abstract]   [Full Text] [Related]  

  • 8. Vasodilator therapy of chronic congestive heart failure.
    Cabaniss CD
    J Med Assoc Ga; 1980 Feb; 69(2):131-2. PubMed ID: 7373170
    [No Abstract]   [Full Text] [Related]  

  • 9. Dose requirements of hydralazine in patients with severe chronic congestive heart failure.
    Packer M; Meller J; Medina N; Gorlin R; Herman MV
    Am J Cardiol; 1980 Mar; 45(3):655-60. PubMed ID: 7355762
    [No Abstract]   [Full Text] [Related]  

  • 10. Hydralazine in the management of chronic congestive heart failure.
    Rosenblum R
    Am J Cardiol; 1985 Jun; 55(13 Pt 1):1664. PubMed ID: 4003322
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of vasodilator therapy on mortality in chronic congestive heart failure.
    Ghose JC; Chakraborty S; Mondal M; Bhandari B
    J Assoc Physicians India; 1993 May; 41(5):269-71. PubMed ID: 8300456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved cardiac performance during exercise following hydralazine treatment in chronic heart failure.
    Conradson TB; Rydén L
    Acta Med Scand; 1984; 216(1):41-5. PubMed ID: 6485880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute and chronic effects of oral hydralazine on left ventricular pump function and renal hemodynamics in chronic left heart failure.
    Mathey D; Hanrath P; Polster J; Witte G; Montz R; Bleifeld W
    Eur Heart J; 1980 Feb; 1(1):25-9. PubMed ID: 7285964
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of cardiac insufficiency with systemic vasodilator agents].
    García Puig J; Gil Aguado A; Arnalich F; Gaspar G; Anciones B; Vázquez JJ
    Med Clin (Barc); 1980 Nov; 75(9):398-403. PubMed ID: 7464335
    [No Abstract]   [Full Text] [Related]  

  • 15. [Vasodilator agents in chronic heart failure: which is the best option?].
    Corbalán R; Kunstmann S; Jalil J
    Rev Med Chil; 1993 Jan; 121(1):81-8. PubMed ID: 8235172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydralazine pharmacodynamics in the dog.
    Kittleson MD; Hamlin RL
    Am J Vet Res; 1983 Aug; 44(8):1501-5. PubMed ID: 6625299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydralazine versus placebo in CHF - preliminary results from a multicenter long term study in Sweden.
    Conradson TB
    Acta Med Scand Suppl; 1981; 652():177-80. PubMed ID: 7036661
    [No Abstract]   [Full Text] [Related]  

  • 18. [Acute and chronic effects of dihydralazine in severe congestive heart failure at rest and during exercise (author's transl)].
    Reifart N; Bunge T; Kaltenbach M; Bussmann WD
    Z Kardiol; 1982 Jan; 71(2):75-81. PubMed ID: 6803467
    [No Abstract]   [Full Text] [Related]  

  • 19. [Peripheral vasodilator agents in cardiology].
    Khomenko VL; Pomerantsev VP; Vasiuk IuA
    Sov Med; 1980; (12):70-5. PubMed ID: 6784251
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of vasodilator therapy in the management of the patient with acute myocardial infarction.
    Wagner GC; Robinson PH
    Prim Care; 1981 Sep; 8(3):467-81. PubMed ID: 6796986
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.